CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN) today announced results for its fourth quarter and full year ended December 31, 2006. Revenues for the fourth quarter were $330 million, resulting in full year sales of $1,263 million, an increase of 5 percent over the $1,198 million reported for 2005.
